Valuation: GKB Ophthalmics Limited

Market Cap 265M 2.78M 2.43M 2.23M 2.08M 3.95M 4.01M 26.81M 10.42M 130M 10.43M 10.21M 448M P/E 2024
-15.6x
P/E 2025 -4.32x
Enterprise Value 280M 2.94M 2.57M 2.36M 2.2M 4.18M 4.24M 28.39M 11.03M 138M 11.05M 10.81M 475M EV / Sales 2024
0.43x
EV / Sales 2025 0.29x
Free-Float
23.12%
Yield 2024 *
-
Yield 2025 -
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
11/08/23 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
1 week-1.47%
Current month-1.84%
1 month-0.93%
3 months+14.64%
6 months+25.62%
Current year+23.17%
1 week 62.14
Extreme 62.14
64.9
1 month 60
Extreme 60
65.94
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 57 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.47%-16.08%-28.82% 3.34M
-1.80%+2.10%-26.91%+1.00% 90.56B
-0.04%-0.29%-21.08%-24.10% 33.41B
+3.13%+4.48%+1.23%-21.36% 14.47B
+0.49%+4.74% - - 9.73B
+12.05%+13.46%-1.96%+591.19% 2.24B
+1.74%+6.95%-28.15%-64.03% 1.46B
+1.76%+8.51%-38.76%-30.03% 856M
+7.35%+15.68%+21.73%+5.97% 895M
+1.49%+0.12%+49.47%-32.58% 784M
Average +2.62%+4.48%-6.72%+44.14% 15.44B
Weighted average by Cap. -0.49%+2.26%-21.73%+1.09%

Financials

2024 2025
Net sales 883M 9.27M 8.1M 7.45M 6.94M 13.17M 13.36M 89.4M 34.75M 434M 34.79M 34.05M 1.49B 1.09B 11.45M 10.01M 9.2M 8.57M 16.26M 16.5M 110M 42.92M 536M 42.97M 42.04M 1.85B
Net income -28.1M -295K -258K -237K -221K -419K -426K -2.85M -1.11M -13.82M -1.11M -1.08M -47.61M -70.45M -740K -647K -594K -554K -1.05M -1.07M -7.14M -2.77M -34.63M -2.78M -2.72M -119M
Net Debt -57.22M -601K -525K -483K -450K -854K -866K -5.8M -2.25M -28.13M -2.26M -2.21M -96.92M 15.59M 164K 143K 132K 123K 233K 236K 1.58M 614K 7.66M 615K 601K 26.41M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
170
Date Price Change Volume
03/07/26 ₹63.11 0.00% 51
02/07/26 ₹63.11 +0.94% 1,006
01/07/26 ₹62.52 -2.75% 589
30/06/26 ₹64.29 +2.62% 1,458
29/06/26 ₹62.65 -2.19% 140